Items Tagged ‘dinutuximab’

April 9th, 2015

Unituxin® Approved for Treatment of Children with High-Risk Neuroblastoma


The U.S. Food and Drug Administration (FDA) has announced the first-ever drug approval for the treatment of children with high-risk neuroblastoma. In clinical trials Unituxin® (dinutuximab) has improved survival among children with this type of cancer who have responded to previous treatment. Neuroblastoma is a type of cancer that develops in the nerve tissues of […]

View full entry

Tags: children, dinutuximab, FDA approval, high-risk, Neuroblastoma, News, Unituxin